Claude designed protein binders in the wet lab while models learned to brainstorm
Anthropic's Claude generated 318,484 protein designs against scorpion neurotoxins over 64 hours; 17 of 211 wet-lab-tested designs bound — with an explicit caveat that this is not an antivenom. Smaller models are learning to brainstorm science and recommend with hypotheses.
- Anthropic researchers asked an internal research model to design protein minibinders against scorpion neurotoxins; Claude generated 318,484 designs over 64 hours, mainly autonomously, using on the order of 10,000 GPU hours. m:…3199
- Adaptyv Bio and Twist Bioscience experimentally tested 211 designs; 17 met the binding criteria (KD of 1 µM or tighter), with the two strongest, Cn2-B1 and Cn2-B2, targeting the Cn2 neurotoxin. m:…3199
- The researchers explicitly say they have not confirmed the binders neutralize venom in a cellular environment and do not claim an antivenom; they are releasing all 211 designs and data as a resource for the field. m:…3199
- In a preprint, an 8B model trained with set-level RL achieved higher creative utility than Claude Opus 4.8 and GPT-6 Astra on a contamination-free benchmark for scientific idea generation, and was judged as promising as Claude Opus 4.8 in a pilot human study. Self-reported m:…4770
- Sakana AI's QD-Rec applies open-ended evolution to decision-making, using candidate-hypothesis pairs; the company reports it outperformed baselines in average ratings and recommendation set size in most settings. Self-reported m:…0825
Claude goes to the wet lab
Anthropic researchers set an internal research model a concrete wet-lab problem: design minibinders — small proteins that attach tightly to a target — against scorpion neurotoxins. Over 64 hours, working mainly autonomously inside the Claude Science environment, Claude generated 318,484 protein designs, a campaign that consumed on the order of 10,000 GPU hours. Claude picked the toxin structures itself by searching the Protein Data Bank and the AlphaFold database. m:…3199
The designs left the computer. Adaptyv Bio and Twist Bioscience experimentally tested 211 of them for binding — Adaptyv in a cell-free system, Twist in mammalian cells — and 17 met the criteria: evidence of binding in every replicate, with every dissociation constant (KD) 1 µM or tighter. The two strongest binders, which the researchers call Cn2-B1 and Cn2-B2, target Cn2, a neurotoxin from the Mexican scorpion Centruroides noxius. The stated motivation is real: scorpions sting 1.2 million people or more each year, causing more than 3,250 deaths. m:…3199
The caveat, stated plainly
Anthropic states the limit plainly, and it is worth carrying in full: the team has not confirmed whether these binders neutralize scorpion venom in a cellular environment, so it does not claim to have produced an antivenom. That is the honest shape of the result — a binding result, not a therapeutic one. The researchers are releasing all 211 designs and their data as a resource for the field, which is the other half of the story: machine-generated protein design campaigns can now be published as open datasets. m:…3199
Models learn to brainstorm
Meanwhile, models are getting better at the part of science that comes before the experiment: coming up with ideas. In a preprint, researchers describe a set-level reinforcement learning objective that trains language models to generate diverse, high-quality, document-grounded ideas — a single generation writes K structured idea cards grounded in source papers, and the set is scored jointly, with each idea weighted by how different it is from the ideas before it. Their 8B model, the paper reports, achieves higher creative utility — quality plus diversity — than Claude Opus 4.8 and GPT-6 Astra on a contamination-free benchmark, and in a pilot human study its idea sets were judged as promising as Claude Opus 4.8's. m:…4770
Sakana AI is pushing a related idea into decision-making with QD-Rec, a recommendation method that applies open-ended exploration — quality-diversity evolution — to decision support. Instead of recommending candidates alone, it recommends candidate-hypothesis pairs: the candidate plus the reasoning for choosing it, with new hypotheses generated by mutation and crossover, and unique perspectives kept as stepping stones even when they aren't currently the best. The company reports it outperformed baselines in average ratings and recommendation set size in most settings across its experiments — company-run experiments, not independent replication. m:…0825
Discovery as a workflow
Reasoning, not reporting: the thread across all three is the loop closing. Claude ran a design campaign end to end and handed it to wet labs; the 8B paper suggests idea generation itself can be trained as a set-level objective rather than left to luck; QD-Rec treats hypotheses as the unit of recommendation. None of this is a breakthrough claim — it is infrastructure for a world where the model does the brainstorming, the experiment, and the triage, and humans set the criteria. The binder campaign is the proof that the loop can touch reality, and the caveat is the proof the authors know the difference. m:…3199 m:…4770 m:…0825
What is still unresolved
- Whether the binders neutralize venom in a cellular environment is untested — no antivenom claim.
- The 8B idea-generation result is a preprint; the human evaluation was a small pilot; there is no independent replication.
- QD-Rec results are company-reported experiments.
- Hit-rate context: 17 of 211 designs met the binding criteria — the campaign's cost-effectiveness versus traditional protein design is not addressed.
Provenance by Synorb. Every claim links to its source. This story was written by an agent from the Manifests listed below. Read the methodology and limitations, or send a correction.
Free to reuse, including commercially. Credit “Hanging Context, with provenance by Synorb” and link to this story. Keep the cited Manifest ids. Reuse terms v1.